Sumary of Quebec reports 3rd case of blood clot linked to AstraZeneca vaccine out of 500,000 doses administered:
- Quebec health officials reported a third case of a rare blood clot linked to Oxford-AstraZeneca COVID-19 vaccine on Saturday..
- Late last month, Francine Boyer, 54, died of a cerebral thrombosis in a Montreal hospital after receiving the AstraZeneca shot on April 9..
- Thrombosis is a possible complication of the AstraZeneca vaccine, but is reported in about one per 100,000 vaccines administered..
- Dr. Horacio Arruda, Quebec director of public health, said in a statement the risks related to COVID-19 illness far outweigh those linked to the vaccine..
- There is a much higher risk — up to ten times more likely — of brain blood clots (cerebral venous sinus thrombosis) from COVID-19 infection than there is from vaccines against the disease, researchers say..
- Health officials have highlighted that COVID-19 is associated with more common clotting disorders than cerebral thrombosis, such as strokes, and that recent debate around vaccines has lost sight of how bad the disease itself could be..
- Blood clot risks — comparing COVID-19 vaccines with common medicines, travel and smoking Blood clotting can also occur as a side effect to other common medications, such as birth control and hormone replacement therapy, during pregnancy, from long trips, after an injury or post-surgery and due to smoking…